273 related articles for article (PubMed ID: 17374722)
1. Role of the chromobox protein CBX7 in lymphomagenesis.
Scott CL; Gil J; Hernando E; Teruya-Feldstein J; Narita M; Martínez D; Visakorpi T; Mu D; Cordon-Cardo C; Peters G; Beach D; Lowe SW
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5389-94. PubMed ID: 17374722
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic role of the chromobox protein CBX7 in gastric cancer.
Zhang XW; Zhang L; Qin W; Yao XH; Zheng LZ; Liu X; Li J; Guo WJ
J Exp Clin Cancer Res; 2010 Aug; 29(1):114. PubMed ID: 20723236
[TBL] [Abstract][Full Text] [Related]
3. Polycomb CBX7 has a unifying role in cellular lifespan.
Gil J; Bernard D; Martínez D; Beach D
Nat Cell Biol; 2004 Jan; 6(1):67-72. PubMed ID: 14647293
[TBL] [Abstract][Full Text] [Related]
4. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.
Yap KL; Li S; Muñoz-Cabello AM; Raguz S; Zeng L; Mujtaba S; Gil J; Walsh MJ; Zhou MM
Mol Cell; 2010 Jun; 38(5):662-74. PubMed ID: 20541999
[TBL] [Abstract][Full Text] [Related]
5. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.
Bernard D; Martinez-Leal JF; Rizzo S; Martinez D; Hudson D; Visakorpi T; Peters G; Carnero A; Beach D; Gil J
Oncogene; 2005 Aug; 24(36):5543-51. PubMed ID: 15897876
[TBL] [Abstract][Full Text] [Related]
6. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.
Jacobs JJ; Scheijen B; Voncken JW; Kieboom K; Berns A; van Lohuizen M
Genes Dev; 1999 Oct; 13(20):2678-90. PubMed ID: 10541554
[TBL] [Abstract][Full Text] [Related]
7. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
[TBL] [Abstract][Full Text] [Related]
8. USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway.
Liu YL; Jiang SX; Yang YM; Xu H; Liu JL; Wang XS
Cell Biochem Biophys; 2012 Jan; 62(1):229-35. PubMed ID: 21928107
[TBL] [Abstract][Full Text] [Related]
9. A novel zinc finger protein Zfp277 mediates transcriptional repression of the Ink4a/arf locus through polycomb repressive complex 1.
Negishi M; Saraya A; Mochizuki S; Helin K; Koseki H; Iwama A
PLoS One; 2010 Aug; 5(8):e12373. PubMed ID: 20808772
[TBL] [Abstract][Full Text] [Related]
10. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways.
Ni SJ; Zhao LQ; Wang XF; Wu ZH; Hua RX; Wan CH; Zhang JY; Zhang XW; Huang MZ; Gan L; Sun HL; Dimri GP; Guo WJ
J Hematol Oncol; 2018 Feb; 11(1):17. PubMed ID: 29422082
[TBL] [Abstract][Full Text] [Related]
11. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
[TBL] [Abstract][Full Text] [Related]
12. CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a).
O'Loghlen A; Brookes S; Martin N; Rapisarda V; Peters G; Gil J
Aging Cell; 2015 Dec; 14(6):1113-21. PubMed ID: 26416703
[TBL] [Abstract][Full Text] [Related]
13. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus.
Dietrich N; Bracken AP; Trinh E; Schjerling CK; Koseki H; Rappsilber J; Helin K; Hansen KH
EMBO J; 2007 Mar; 26(6):1637-48. PubMed ID: 17332741
[TBL] [Abstract][Full Text] [Related]
14. Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus.
Li Q; Wang X; Lu Z; Zhang B; Guan Z; Liu Z; Zhong Q; Gu L; Zhou J; Zhu B; Ji J; Deng D
PLoS One; 2010 Oct; 5(10):e13732. PubMed ID: 21060834
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
Bertwistle D; Sherr CJ
Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893
[TBL] [Abstract][Full Text] [Related]
17. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
19. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
Kim HY; Park JH; Won HY; Lee JY; Kong G
FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
[TBL] [Abstract][Full Text] [Related]
20. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
